What amount sold does Tidal Diagnostic Solutions Inc. report in Form D filings?

The latest linked filings report $20K sold across 2 identified offering(s). 1 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Tidal Diagnostic Solutions Inc.'s most recent SEC filing?

Tidal Diagnostic Solutions Inc.'s most recent Form D filing was on 2026-03-03.

How many investors does Tidal Diagnostic Solutions Inc. have?

The most recent Form D filing lists 1 investor(s).

Tidal Diagnostic Solutions Inc.

CIK: 0002089685·Biotechnology·SCARBOROUGH, ME·Corporation·Founded 2025

Reported Sold

$20,000

Total Filings

Identified Offerings

Last Filed

Mar 3, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 1 unlinked amendment excluded.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Mar 3, 2026Form D — New notice

Reported sold: $20,000 · Target: $500,000

Rule 506(b)·1 investor

Jan 22, 2026Form D/A — Amendment

Reported sold: $227,000 · Target: $300,000

No verified predecessor available.

Section 4(a)(2)·15 investors

Oct 17, 2025Form D — New notice

Reported sold: $0 · Target: $200,000

Section 4(a)(2)·0 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

33%

Latest reported sold across 2 identified offerings

$20,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

1 unlinked amendment excluded.

Key People

David Kuhrt

Executive Officer, Director

Appears on 3 filings

Tyler Schleicher

Executive Officer, Director

Appears on 3 filings

Suzanne Vogel

Executive Officer, Director

Appears on 3 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Mar 3, 2026	New	$500,000	$20,000	1
Jan 22, 2026	Amendment	$300,000	$227,000	15
Oct 17, 2025	New	$200,000	$0	0

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Opus KSD, Inc.

Biotechnology

Offering target: $680,801

Filed Oct 1, 2026